Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer
1 other identifier
interventional
176
0 countries
N/A
Brief Summary
Experimental studies have shown the chemopreventive properties of green tea extract (GTE) on colorectal cancer. And colorectal adenomas are precursors to colorectal cancers. The aim of this study is to determine the preventive effect of GTE supplements on metachronous colorectal adenomas by giving GTE tablets of which are equivalent of 9 cup-of-green tea per day (0.9 g/day GTE, 0.6 g/day Epigallocatechin gallate (EGCG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2010
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 17, 2014
CompletedFirst Posted
Study publicly available on registry
December 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedOctober 28, 2015
October 1, 2015
4.8 years
December 17, 2014
October 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence/Number/Size of metachronous colorectal adenoma(s)
1 year
Secondary Outcomes (4)
Recurrence/Number/Size of metachronous colorectal polyp(s) including hyperplastic polyp(s)
1 year
Change of lipid profiles after green tea extract (GTE) supplementation
1 year
Change of body weight, BMI and waist circumference
1 year
Adverse effect(s) of GTE supplementation
every 1-3 months till the end of study protocol (12 months)
Study Arms (2)
Control
NO INTERVENTIONWithout green tea extract (GTE) supplementation
GTE group
EXPERIMENTALGTE supplementation for 12 months after polypectomy for colorectal adenomatous polyps
Interventions
6 GTE tablets per day. Daily dose is equivalent of 9 cup-of-green tea per day (0.9 g/day GTE, 0.6 g/day epigallocatechin gallate \[EGCG\]).
Eligibility Criteria
You may qualify if:
- \- subjects who present one or more adenomatous polyps on colonoscopy.
You may not qualify if:
- subjects who denied to participate in this study
- subjects who present inflammatory bowel diseases such as ulcerative colitis or crohn's disease
- subjects who received partial or total colectomy due to colon cancer or other colonic diseases.
- subjects who are pregnant
- subjects who are on aspirin or NSAIDS for any reasons
- subjects who have received a transplant of any major organ or who are on immunosuppressants for any reason
- subjects who are unable to perform a bowel prep or who present poor bowel prep for colonoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H, Suganuma M, Fujiki H, Moriwaki H. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3020-5. doi: 10.1158/1055-9965.EPI-08-0528.
PMID: 18990744RESULTStingl JC, Ettrich T, Muche R, Wiedom M, Brockmoller J, Seeringer A, Seufferlein T. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer. 2011 Aug 18;11:360. doi: 10.1186/1471-2407-11-360.
PMID: 21851602RESULTShin CM, Lee DH, Seo AY, Lee HJ, Kim SB, Son WC, Kim YK, Lee SJ, Park SH, Kim N, Park YS, Yoon H. Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial. Clin Nutr. 2018 Apr;37(2):452-458. doi: 10.1016/j.clnu.2017.01.014. Epub 2017 Jan 29.
PMID: 28209333DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dong Ho Lee, M.D., Ph.D.
Seoul National Universtiy Bundang Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2014
First Posted
December 22, 2014
Study Start
August 1, 2010
Primary Completion
May 1, 2015
Study Completion
October 1, 2015
Last Updated
October 28, 2015
Record last verified: 2015-10